发明名称 OPHTHALMOLOGIC IRRIGATION SOLUTIONS AND METHOD
摘要 Solutions for perioperative intraocular application by continuous irrigation during ophthalmologic procedures are provided. These solutions include multiple agents that act to inhibit inflammation, inhibit pain, effect mydriasis (dilation of the pupil), and/or decrease intraocular pressure, wherein the multiple agents are selected to target multiple molecular targets to achieve multiple differing physiologic functions, and are included in dilute concentrations in a balanced salt solution carrier.
申请公布号 US2017100412(A1) 申请公布日期 2017.04.13
申请号 US201615198208 申请日期 2016.06.30
申请人 Omeros Corporation 发明人 Demopulos Gregory A.;Palmer Pamela Pierce;Herz Jeffrey M.
分类号 A61K31/573;A61K9/08;A61K31/192;A61K31/445;A61K31/137;A61K31/4409;A61K31/4174;A61K31/167;A61K9/00;A61K31/5377 主分类号 A61K31/573
代理机构 代理人
主权项 1. A composition for use in perioperatively inhibiting ocular inflammation and maintaining mydriasis during an intraocular ophthalmologic procedure, comprising an anti-inflammatory agent and a mydriatic agent in a physiologic irrigation solution for intraocular delivery, wherein the anti-inflammatory agent comprises a non-steroidal anti-inflammatory drug (NSAID) and the mydriatic agent comprises an alpha-1 adrenergic receptor agonist, wherein the NSAID and the alpha-1 adrenergic receptor agonist are included at concentrations less than that used for conventional topical or systemic delivery and in a therapeutically effective amount for the maintenance of mydriasis during the procedure and the reduction of postoperative pain when delivered intraocularly during the intraocular ophthalmologic procedure.
地址 Seattle WA US